Establishing Novel Models of Interdisciplinary Care to Improve Survival Outcomes in Patients with Cancer: A Conversation with Diane M. Simeone, MD
|
Moores Cancer Center Director Diane M. Simeone, MD, sat down with the ASCO Post to share insights into her career and the importance of collaboration in improving cancer care for patients. Learn More>>
|
Take that Cancer, You Big Jerk: How Clinical Trials Saved Me
|
At just 39 years old, Michelle Brubaker was diagnosed with an aggressive form of breast cancer. Now eight years in remission, she joined us for Clinical Trials Patient Appreciation Day to share her story of strength, perseverance and hope. Learn More>>
|
More Smokers Quit After Big Hike in California Tobacco Tax
|
In a recently published study, Moores member Shu-Hong Zhu, PhD, and colleagues from UC San Francisco found that increasing taxes on tobacco products has shown to be an effective way to increase smoking cessation. After the passage of Proposition 56, California’s three-month quit rate increased 2.7%. Learn More>>
|
To Study Cancer “Kill Switch,” UC San Diego Scientists Will Send Stem Cells to Space
|
Stem cells from the Sanford Stem Cell Institute are headed to the International Space Station this spring for further research into a promising anti-cancer drug. Director of SSCI and Moores member Catriona Jamieson, MD, PhD, shares insights into the benefits of space-based research and the development of this new treatment. Learn More>>
|
|
|
| Global Variations in Patterns of Care for Retroperitoneal Sarcoma
|
Jason K. Sicklick, MD, FACS (Structural and Functional Genomics)
|
|
|
| Association of Homologous Recombination Repair Alterations With Outcomes in Patients with Metastatic Hormone-Sensitive Prostate Cancer |
Rana R. McKay, MD, FASCO (Solid Tumor Therapeutics)
|
|
|
| Tumor-Associated Glycan Exploits Adenosine Receptor 2A Signaling to Facilitate Immune Evasion |
Alice L. Yu, MD, PhD (Solid Tumor Therapeutics)
|
|
|
FEATURED FUNDING OPPORTUNITIES
|
Funding Opportunities Available on the Moores Cancer Center Website |
Explore curated funding opportunities from federal, non-federal, limited submission and internal sources, tailored to provide support for cancer research at every stage.
|
| |
CLINICAL TRIALS OFFICE (CTO) |
|
|
UCSD 812773: sIND: Single Patient Expanded Access of Donor-Derived AntiCD33 Chimeric Antigen Receptor Expressing T Cells (VCAR33) for 40-Year-Old Patient G-D
PI: Dimitrios Tzachanis, MD, PhD
NCT ID: Not in CT.gov
|
|
|
|
